World of DTC Marketing

JUNE 15, 2021

Doctors using telemedicine software are not sure of its value to patients and believe telehealth may pose risks. As one thought leader told me, “I need to see patients in person when they come in for a specific problem.” Billion by 2027, growing at a CAGR of 16.4% from 2020 to 2027.

Side effects 193

Side effects Insurance Doctors Pharma 193

Impetus Digital

MARCH 15, 2024

In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). The field of oncology is rapidly growing and evolving.

Recruitment 78

Recruitment Healthcare Provider Patients Healthcare 78

European Pharmaceutical Review

JANUARY 19, 2023

The contribution will enable the programme to reach additional physicians and medical students, further expanding the initiative that aims to extend the reach of clinical trials in underserved patient populations in US communities. The Winn Award Program has so far trained 114 early-stage investigator physicians.

Food and Drug Administration 80

Food and Drug Administration Physicians Medicine Food 80

pharmaphorum

JANUARY 17, 2023

” The combination has the potential to deliver higher accuracy in assisting with the diagnosis of a disease in a healthcare setting, or monitoring progression for a clinical trial, according to a statement on the transaction. million) to its top-line in 2023 with “considerable growth” next year.

Marketing 97

Marketing Healthcare Healthcare Patients 97

PM360

SEPTEMBER 21, 2023

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Insurance approval and distribution for specialty drugs can cause significant treatment delays up to three to four weeks for many patients.

Prescription 52

Prescription Medical Patients Distribution 52

Medico Reach

DECEMBER 2, 2022

To bring effective medicines and Innovations in healthcare industry , a Clinical Research Organization or Contract Research Organization (CRO) are a must for the Biotech, Medtech, and pharma industries. billion , and by 2027, it is expected to reach around an exciting amount of 115.1 from 2022 to 2027. from 2022 to 2027.

Consulting 98

Consulting Specialization Medicine Medical 98

PM360

DECEMBER 14, 2022

In its latest venture into the healthcare arena, Amazon is reaching out directly to the consumer via its soon-to-be-launched Amazon Clinic , a virtual health service for patients to see licensed clinicians about common medical issues. billion euros into its new facility where it is planning to hire 400 and 500 new personal by 2027.

Manufacturing 52

Manufacturing Medical Healthcare Healthcare 52

PM360

APRIL 7, 2023

Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders. This will create confusion in the marketplace and may possibly lead to delivery of misinformation to healthcare providers (HCPs) regarding a brand’s drug coverage,” Bambalas says.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

PM360

JUNE 29, 2022

Healthcare and pharma companies are watching this trend and refining their strategies to meet tomorrow’s health consumer. But to succeed, players must deeply understand both the end-to-end consumer and patient experience and create an ecosystem of partners to deliver the care, products, and experiences that health-conscious consumers need.

Retail 97

Retail Healthcare Healthcare Marketing 97

Clarivate

OCTOBER 25, 2023

The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. The biggest impacts are likely to be felt by patients with PDPs that use coinsurance, which most plans do for specialty drugs.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Medico Reach

FEBRUARY 8, 2023

Hence, looking closer at the future trends in pharma industry only makes sense for businesses to stay afloat in the healthcare market. Here are some more applications of AI in healthcare and pharma Medicines discovery and design can improve drastically. billion by 2027. billion in big data analytics.

Pharma 52

Pharma Medicine Marketing Prospecting 52

PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. However, the impact of the new law will reverberate in the industry for years to come.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

European Pharmaceutical Review

MARCH 4, 2024

percent through 2027. Therefore, biologics identification and characterisation poses unparalleled challenges, as does their manufacturing processes and routes of administration while maintaining patient safety and clinical efficacy. Standardising isolation, purification and storage processes are crucial areas for further improvement.

Food and Drug Administration 88

Food and Drug Administration Transportation FDA Medical 88

Star OUTiCO

FEBRUARY 18, 2022

For pharma and the NHS, this manifested itself in unprecedented changes to the way the latter delivers patient care, while the former – historically a little conservative on the digital uptake – became a beacon of inspiration for what’s possible when there is a strong sense of urgency. The ultimate benefactor, of course, is the patient.”

Pharma 52

Pharma Healthcare Healthcare Patients 52

Legacy MEDSearch

JULY 24, 2023

Trial results are expected in 2027. SAINT therapy is the beginning of a revolution in psychiatry: fast, effective, and personalized treatments that give hope to patients who have failed to receive relief from traditional approaches,” said David Carreon, M.D.,

Medical 52

Medical Recruitment FDA Specialization 52

Curzon Consulting

DECEMBER 14, 2022

billion by the end of 2027. . The additional savings can be used to reinvest in new equipment , upgrades and/or drive digital transformation programmes to enhance productivity of the radiology department and improve administration, technician, clinician and patient experience. . billion in 2022 and is expected to reach USD 1.5

Insurance 52

Insurance Management Manufacturing Marketing 52

Evolve Your Success

OCTOBER 31, 2023

Neuromodulation isn’t just about stimulating nerves; it’s about awakening hope and transforming lives—one patient at a time. In this episode, Blake Williams takes us on a wild journey through his career as a Field Clinical Engineer (FCE), shedding light on the incredible impact of neuromodulation on the lives of patients.

Engineering 52

Engineering Sales Medical sales Physicians 52

pharmaphorum

JANUARY 16, 2023

The present article focuses on opportunity, the unmet need which lies at the heart of better healthcare provision, and two areas of growth and opportunity: Point of Care Diagnostics, and the new pharmacotherapy classes which will commercialise for the first time in 2023. Innovation will power the market.

FDA 84

FDA Healthcare Healthcare Medicine 84

European Pharmaceutical Review

OCTOBER 12, 2023

With the goal of supplying cell therapies, vaccines and other essential medicines such as antibody drugs to patients, the facilities aim to address major supply challenges and navigate the intricacies of producing fragile biological products. Meath opened last month.

Pharmaceutical manufacturing 84

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 84

European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. We have confirmed this in close to 100 subjects who have swallowed the RP.”

Food and Drug Administration 88

Food and Drug Administration Manufacturing Safety Pharmaceutical 88

European Pharmaceutical Review

FEBRUARY 7, 2023

In addition, the devices must not present an unacceptable risk to patient and user health and safety as established in Articles 94 and 95 of the MDR. Edward Turtle is a products lawyer, regulatory advisor and litigator with particular experience in the healthcare, technology and consumer product sectors. of the MDR and Article 110.4

Government 94

Government Medical Medicine Marketing 94

Pharmaceutical Technology

APRIL 24, 2023

Zoetis, one of the world’s leading animal healthcare companies, recently partnered with Syngene to manufacture a drug substance for bedinvetmab, a first-in-class monoclonal antibody used for treating osteoarthritis in dogs. GlobalData forecasts Biologics to significantly overtake sales of small molecules by $120 billion by 2027.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Medical 98

Medical Manufacturing Insurance Side effects 98

World of DTC Marketing

APRIL 12, 2022

healthcare system is bedeviled by greed, with drug companies, device manufacturers, hospital organizations, physician groups, and insurers scrambling to grab a slice of the more than $3 trillion we spend on medical care each year. spends far more than most of the world on healthcare but receives only middling outcomes by OECD standards.

Healthcare 209

Healthcare Healthcare Insurance Physicians 209

Pharmaceutical Technology

FEBRUARY 6, 2023

After 12 weeks, the study met its primary endpoint related to the “number of participants with treatment-related adverse events and laboratory abnormalities” for patients in the 320mg group, as there were no study-related adverse events. The company plans to release the final data in Q2 2023.

Marketing 59

Marketing Pharmaceutical FDA Prospecting 59

World of DTC Marketing

JULY 28, 2022

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. This would include drugs covered by both Medicare Part B (physician-administered drugs) and Part D (prescription medications).

Pharma 256

Pharma Prescription Manufacturing Insurance 256